Market Place
Sourcing Support
All News #Library
Rare Diseases
Lisata`s Certepetide Granted FDA Orphan Drug Designation
05 Sep 2024 //
GLOBENEWSWIRE
Lisata Therapeutics Announces FDA Orphan Drug Designation Granted to LSTA1
09 Apr 2024 //
GLOBENEWSWIRE
Lisata clinches rare disease status for osteosarcoma drug
22 Mar 2024 //
PHARMACEUTICAL TECHNOLOGY
Lisata Announces U.S. FDA Rare Pediatric Disease Designation Granted to LSTA1
21 Mar 2024 //
GLOBENEWSWIRE
Lisata Announces EMA Has Granted LSTA1 Orphan Drug Designation
17 Oct 2023 //
GLOBENEWSWIRE
Lisata Announces U.S. FDA Orphan Drug Designation Granted to LSTA1
08 Aug 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.